06/18/2019

Recent Oncology Related Drug News

Amgen, Merck, and Eli Lilly Sue Over Trump Administration Policy to Require Drug Prices in TV Ads

A trio of pharmaceutical manufacturers on Friday filed suit to overturn one of the most impactful drug pricing policies the Trump administration has enacted to date: a requirement that the companies include a medicine’s list price in direct-to-consumer advertising.  READ MORE

What Pharmacists Should Know About the Pitfalls of Step Therapy

Although the Centers for Medicare and Medicaid Services (CMS) has recently authorized a policy that allows step therapy for Medicare Part B drugs for patients with Medicare Advantage, the practice is detrimental to patients, according to members of the Community Oncology Alliance (COA). READ MORE